1
/
of
0
FDA Drug Approval, N019523, CYSTEINE HYDROCHLORIDE
FDA Drug Approval, N019523, CYSTEINE HYDROCHLORIDE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 019523
Company: HOSPIRA
Drug Name: CYSTEINE HYDROCHLORIDE
Active Ingredients: CYSTEINE HYDROCHLORIDE
Strength: 7.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 10/22/1986
Marketing Status: Discontinued
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: HOSPIRA
Drug Name: CYSTEINE HYDROCHLORIDE
Active Ingredients: CYSTEINE HYDROCHLORIDE
Strength: 7.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 10/22/1986
Marketing Status: Discontinued
Submission Classification: Type 5 - New Formulation or New Manufacturer
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details